Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at United Therapeutics UTHR is 30.05%. United Therapeutics' revenue for the same period is $1.01 billion.
The trailing-twelve-month profit margin at Warner Chilcott plc WCRX is 18.89%. Warner Chilcott's operating margin for the same period is 32.10%.
The trailing-twelve-month profit margin at Dr. Reddy's Laboratories RDY is 14.36%. Dr. Reddy's ROE for the same period is 25.28%.
The trailing-twelve-month profit margin at Cubist Pharmaceuticals CBST is 10.23%. Cubist Pharmaceuticals' PEG ratio is 2.13.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in